Eli Lilly has announced the pricing for its diabetes treatment Mounjaro in India. The 2.5 mg vial of Mounjaro is priced at 3,500 rupees, while the 5 mg vial is priced at 4,375 rupees. This pricing strategy aims to make the medication more accessible to patients in India, where diabetes management is a significant healthcare concern. Mounjaro, known for its effectiveness in managing blood sugar levels, is part of Lilly's efforts to expand its presence in the Indian pharmaceutical market.
	
	Source: Reuters, Eli Lilly and Company